Verrica Pharmaceuticals Inc

NASDAQ:VRCA   3:10:04 PM EDT
3.08
-0.31 (-9.14%)
Other Pre-Announcement

Verrica Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:35 GMT
Verrica Pharmaceuticals Inc (VRCA) - Verrica Pharmaceuticals Reports Third Quarter 2022 Financial Results.
Says Reiterates Expectation to Resubmit NDA for Vp-102 for Molluscum Contagiosum in Q1 2023.
Q3 GAAP Earnings per Share $0.00.
Q3 Non-GAAP Earnings per Share $0.07.
Qtrly License Revenues $8.32 Million.
Q3 Earnings per Share View $-0.11, Revenue View $4.3 Million -- Refinitiv Ibes Data (analyst estimates).